The 70/85 kDa ribosomal protein S6 kinase is regulated through the concerted actions of multiple phosphatases and kinases. A newly identified S6 kinase kinase, NEK6, appears to provide the penultimate activation step. Phosphorylation of the ribosomal subunit S6 is one of the oldest known phosphorylation events in cell proliferation control. Over the past three decades, two protein kinases that can phosphorylate S6 have been characterized. One, p90 ribosomal S6 kinase (p90 Rsk), is activated through mitogen-activated protein (MAP) kinase pathways [1] . The other, referred to as p70/p85 S6 kinase (S6K), has a more convoluted mechanism of activation and inactivation. This issue of Current Biology includes a report from Avruch and colleagues [2] that adds yet another layer to the processes that lead to S6K activation, involving a member of the NIMA protein kinase family termed NEK6.
Phosphorylation of the ribosomal subunit S6 is one of the oldest known phosphorylation events in cell proliferation control. Over the past three decades, two protein kinases that can phosphorylate S6 have been characterized. One, p90 ribosomal S6 kinase (p90 Rsk), is activated through mitogen-activated protein (MAP) kinase pathways [1] . The other, referred to as p70/p85 S6 kinase (S6K), has a more convoluted mechanism of activation and inactivation. This issue of Current Biology includes a report from Avruch and colleagues [2] that adds yet another layer to the processes that lead to S6K activation, involving a member of the NIMA protein kinase family termed NEK6.
Biological function of S6K
Because it phosphorylates the ribosomal protein S6, S6K has been suspected to be a regulator of translation [3] . S6K controls expression of some specific mRNAs, particularly those that contain 5′ terminal oligopyrimidine sequences [4] , and activation of S6K coincident with mitogenic stimulation may be consistent with the general increase in protein synthesis seen in replicating cells. The picture is complicated by the fact that Saccharomyces cerevisiae S6 mutants that lack the S6K-mediated serine phosphorylation site grow normally [5] . But as no homolog of S6K has been identified in the yeast genomes, translational control mechanisms in yeast may differ substantially from mammalian cells.
A role for S6K in cell-cycle regulation was proposed in the light of studies showing that neutralizing antibodies against S6K injected into fibroblasts arrested these cells in G1 [6] . Other evidence also supports the notion that S6K is a cell-cycle regulator, for example the drug rapamycin, which blocks S6K activation by inhibiting the mTOR kinase (see below), is a potent inhibitor of cellcycle transition and induces G1 arrest. Rapamycin inhibits expression of cyclin D3, resulting in inhibition of pRb and p107 phosphorylation [7] , leading to the hypothesis that S6K, or at least mTOR, may activate cyclin D3 transcription or translation.
In addition to cell cycle, S6K also appears to control cell size: targeted disruption of the S6K1 gene results in viable, but small mice that apparently survive owing to expression of S6K-related kinases [8] . Similarly, inactivation of the homolog of S6K in Drosophila leads to reduction in cell growth -that is, smaller cells rather than fewer cells [9] . Control of cell size appears to be consistent with a function of S6K in translational control, but is harder to reconcile with a role for S6K in cell-cycle control.
Downstream regulation of S6K by protein phosphatases
S6K activity can be completely quenched in cells treated with the drug rapamycin [10, 11] or in cells subjected to amino acid starvation [12] , or osmotic shock [13] . While some reports have concluded that rapamycin blocks an upstream activation process, other reports have shown that each of these inhibitory stimuli activates a protein phosphatase that results in rapid dephosphorylation of specific residues on S6K and thereby loss of S6K activity. Curiously, while S6K has been found associated with the PP2A phosphatase [14] , the PP2A inhibitor okadaic acid does not block S6K inhibition mediated by rapamycin or osmotic shock. However, the broad spectrum phosphatase inhibitor calyculin A reverses the negative effect of all of these inhibitory stimuli [12, 13] .
This scenario is reminiscent of the function of rapamycin in regulating phosphatase function in yeast. In both mammalian cells and yeast, rapamycin binds to the peptidyl-prolyl isomerase FKBP12, which then targets a kinase termed target of rapamycin or TOR [15] ; mammalian forms are also known as FRAP or RAFT. In yeast, TOR phosphorylates TAP42, a docking protein for PP2-related phosphatases [16] . The mammalian homolog of TAP42 is termed alpha 4, which has been shown to bind PP2A, PP4, and PP6 [17] . Attractive models can be drawn in which rapamycin-mediated inhibition of mTOR liberates active phosphatases from alpha 4 that then lead to S6K inhibition.
Upstream regulation of S6K by protein kinases
S6K is regulated by several distinct kinases or kinase families. Figure 1 summarizes the known S6K phosphorylation sites. The full-length S6K polypeptide is inhibited by autoregulatory sequences flanking the kinase domain at both the amino terminus and carboxyl terminus [18, 19] . A portion of the carboxy-terminal regulatory domain is sometimes called the pseudosubstrate domain by analogy to sequences that contribute to regulation of protein kinase C (PKC). This sequence, between codons 434 and 452, is multiply phosphorylated in cells stimulated with mito-gens, and this phosphorylation contributes to the multiple slower-migrating bands of S6K seen on SDS gels. The Erk MAP kinase, and probably other MAP kinases, appear to be responsible for phosphorylation of these sequences [20] . Expression in mammalian cells of deletion mutants lacking these inhibitory sequences results in a tremendously activated kinase that is relatively resistant to the effects of rapamycin [18, 19] . These truncated kinases are not active when expressed in bacteria, however, demonstrating a requirement for mammalian kinases that target the residual catalytic domain of S6K.
Several additional phosphorylation sites of S6K have been identified through peptide mapping and phosphorylation site mutagenesis. Threonine 252, which lies within the activation loop, is required for kinase activity [21] : for many other kinases, an activating phosphorylation event in the corresponding domain is similarly required. The 3-phosphoinositide-dependent protein kinase PDK1 strongly phosphorylates this site, and contributes to activation of S6K [22] . The identification of PDK1 as a required activator of S6K serves to explain the sensitivity of S6K to phosphatidylinositol 3-kinase inhibitors such as wortmannin.
To make the situation more complex, PDK1 is poorly able to activate S6K unless residues other than Thr252 are phosphorylated beforehand [22] . This is true even using deletion mutants lacking the pseudosubstrate autoinhibitory domains between codons 434 and 452. For PDK1 to efficiently phosphorylate Thr252, prior phosphorylation at the distal sites Ser394, Thr412 and/or Thr427 is required. These residues lie within a hydrophobic sequence that is similar to a region in the PKC and PKB/Akt kinases, which are also activated by phosphorylation in this domain. Of these sites, phosphorylation of S6K residue Thr412 appears to be the most significant for allowing PDK1 to phosphorylate within the activation loop.
The unanswered question to this point is, what kinase phosphorylates Thr412? Both mTOR and PDK1 have been reported to be able to phosphorylate this residue, [22, 23] , although the rate of phosphorylation of Thr412 by PDK1 preparations is much lower than of Thr252. Additional evidence for the role of PDK1 in regulating phosphorylation of Thr412 is that transfection of active or inhibitory alleles of PDK1 affect Thr412 phosphorylation [24] . Also, mouse cells lacking PDK1 [25] do not phosphorylate Thr412 of S6K (referred to as Thr389 in that reference), and also lack phosphorylation of the analogous Ser473 residue in PKB/Akt. Case closed?
NEK6 as an S6K activator
The paper from Avruch's lab [2] points to the culprit in phosphorylation of Thr412 as being a homolog of the NIMA kinase, termed NEK6. This work describes the purification of a protein that can activate a form of S6K that lacks the autoinhibitory domains. The purified S6K-activating fractions contained NEK6 and the closely related protein NEK7. NEK6 protein expressed from cDNAs phosphorylated Thr412 of S6K directly, and synergized with PDK1 in in vitro activation of S6K, particularly when NEK6 was incubated with S6K before PDK1. Other sites of S6K phosphorylation by NEK6 remain uncharacterized. S6K domain structure and phosphorylation sites. Two isoforms of p70/p85 S6K are known; the codon numbering of 85 kDa S6K is used in this review, the 70 kDa form initiates at codon 24. The catalytic domain (pink) is flanked by regulatory domains (green) that when deleted result in high catalytic activity. A hydrophobic domain (similar to domains in PKB and PKC) that is required for catalytic activity lies distal to the kinase domain and is shown in blue. Within the inhibitory domains, codon Ser40 is phosphorylated by casein kinase 2, but does not appear to contribute to S6K activation. Five Ser-Pro/Thr-Pro codon pairs between 434 and 452 are phosphorylated by MAP kinase(s), which promote S6K activation. Within the kinase activation loop, codon Thr252 is required for S6K activity; this residue is phosphorylated by PDK1. Within the blue flanking domain, codons Ser394, Thr412, and Thr427 are phosphorylated; of these codon Thr412 appears to be most significant in promoting S6K activation. Avruch's paper [2] points to NEK6 as being responsible for Thr412 phosphorylation. The involvement of NIMA-related kinases in growth signal transduction is somewhat surprising. NIMA was first identified in Aspergillus as a gene normally expressed in G2, which when overexpressed caused chromatin condensation and premature M phase entry [26] . The NIMA kinase associates with mitotic spindles and phosphorylates the mitotic histone H3 [27] possibly explaining the observed chromatin condensation. Seven NIMA-related kinases -termed NEKs -have been identified in human cells. The bestcharacterized of these is NEK2, which is associated with centrosomes and appears to induce centrosomal division [28] . This is consistent with a role in the cell cycle similar to the original NIMA kinase. No biochemical characterization of other NEKs has been published to date, although the chromosomal location of NEK6 has been reported [29] . The work from Avruch and colleagues provides the first evidence for a physiological substrate for NEK6.
Open questions
The identification of the NEK kinase family as upstream regulators of S6K adds a new layer of complexity to its regulation (see Figure 2) . Activation of S6K now appears to require the coordinated action of at least three kinase families, possibly casein kinase 2, then the MAP kinases, the NEKs, and PDK1 sequentially. As the regulation of NEK6 itself is completely unknown, the current finding opens the possibility that unidentified physiological pathways may contribute to S6K activation. Left unexplained by this model is the absence of Thr412 phosphorylation in cells lacking PDK1 [25] . Perhaps PDK1 itself provides a required upstream event in activation of NEK6? Like S6K, PKB/Akt is also regulated by PDK1-mediated phosphorylation within the activation loop and by phosphorylation within the hydrophobic domain at a residue corresponding to Thr412 of S6K. Perhaps NEK6 or other NEK homologs play a role in activating PKB/Akt? The identification of NEK6 as an activator of S6K also raises the question of whether it might explain other S6K regulatory events. Since the S6K mutant Thr412Glu is at least partially resistant to the effects of rapamycin [30] , perhaps the rapamycin-activated phosphatase targets NEK6 rather than S6K itself? These questions will probably be resolved soon. While its history predates most of its mitogenically activated kinase peers, unraveling the tangled pathways of S6K activation continues to reveal more at the core.
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Figure 2
Model of sequential activation of S6K by different kinase families. Unphosphorylated S6K is held in the inactive state by inhibitory domains flanking the catalytic domain. Phosphorylation on Ser40 by casein kinase 2 (CK2, step 1) appears to be constitutive and is not absolutely required for activity. Phosphorylation within the carboxy-terminal autoinhibitory domain (step 2) is accomplished by MAP kinases or other proline-directed kinases. Phosphorylation of residue Thr412 (step 3) is accomplished by NEK6/7. The role and regulation of the adjacent sites Ser394 and Thr427 remains to be determined. Ultimately, PDK1 phosphorylates residue Thr252 within the activation loop, completing the activation process. See text for references. N, amino terminus; C, carboxyl terminus. 
